Zerr K J, Furnary A P, Grunkemeier G L, Bookin S, Kanhere V, Starr A
Albert Starr Academic Center for Cardiac Surgery, Providence St. Vincent Hospital & Medical Center, Portland, Oregon 97225, USA.
Ann Thorac Surg. 1997 Feb;63(2):356-61. doi: 10.1016/s0003-4975(96)01044-2.
Elevated blood glucose levels in the postoperative period are associated with an increased risk of deep wound infection in diabetic individuals undergoing open heart operations at Providence St. Vincent Hospital.
Of 8,910 patients who underwent cardiac operations between 1987 and 1993, 1,585 (18%) were diabetic. The rate of deep sternal wound infections in diabetic patients was 1.7%, versus 0.4% for nondiabetics. Nine hundred ninety patients had their operation before implementation of the protocol and 595 after implementation. Charts of all diabetic patients were reviewed. Mean blood glucose levels were calculated from documented results of finger-stick glucometer testing.
Thirty-three diabetic patients suffered 35 deep wound infections: 27 sternal (1.7%) and eight at the donor site (0.5%). Infected diabetic patients had a higher mean blood glucose level through the first 2 postoperative days than noninfected patients (208 +/- 7.1 versus 190 +/- 0.8 mg/dL; p < 0.003) and had a greater body mass index (31.5 +/- 1.4 versus 28.6 +/- 0.1 kg/m2; p < 0.05). Multivariable logistic regression showed that mean blood glucose level for the first 2 days (p = 0.002), obesity (p < 0.002), and use of the internal mammary artery (p < 0.02) were all independent predictors of deep wound infection. Institution of a protocol of postoperative continuous intravenous insulin to maintain blood glucose level less than 200 mg/dL was begun in September 1991. This protocol resulted in a decrease in blood glucose levels for the first 2 postoperative days and a concomitant decrease in the proportion of patients with deep wound infections, from 2.4% (24/990) to 1.5% (9/595) (p < 0.02).
The incidence of deep wound infection in diabetic patients was reduced after implementation of a protocol to maintain mean blood glucose level less than 200 mg/dL in the immediate postoperative period.
在普罗维登斯圣文森特医院接受心脏直视手术的糖尿病患者术后血糖水平升高与深部伤口感染风险增加相关。
在1987年至1993年间接受心脏手术的8910例患者中,1585例(18%)为糖尿病患者。糖尿病患者深部胸骨伤口感染率为1.7%,非糖尿病患者为0.4%。990例患者在方案实施前接受手术,595例在实施后接受手术。对所有糖尿病患者的病历进行了回顾。根据手指血糖仪检测的记录结果计算平均血糖水平。
33例糖尿病患者发生35例深部伤口感染:27例为胸骨感染(1.7%),8例为供体部位感染(0.5%)。感染的糖尿病患者术后头2天的平均血糖水平高于未感染患者(208±7.1对190±0.8mg/dL;p<0.003),且体重指数更高(31.5±1.4对28.6±0.1kg/m2;p<0.05)。多变量逻辑回归显示,术后头2天的平均血糖水平(p=0.002)、肥胖(p<0.002)和使用乳内动脉(p<0.02)均为深部伤口感染的独立预测因素。1991年9月开始实施术后持续静脉注射胰岛素以维持血糖水平低于200mg/dL的方案。该方案导致术后头2天血糖水平下降,深部伤口感染患者比例随之下降,从2.4%(24/990)降至1.5%(9/595)(p<0.02)。
实施在术后即刻维持平均血糖水平低于200mg/dL的方案后,糖尿病患者深部伤口感染的发生率降低。